Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peanut ILIT for Peanut Allergy
NCT04200989Phase 2Withdrawn
- Sponsor
- Scripps Health
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of peanut allergen extract in peanut allergy, sponsored by Scripps Health. Planned start Mar 2021; status: withdrawn.
02
Drugs
peanut allergen extract
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT04200989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200989.